Done sou Salè H1B

Akèy › Anplwayè › Vertex Pharmaceuticals Incorporated › Stem Cell Principal Research Associate

Stem Cell Principal Research Associate nan Vertex Pharmaceuticals Incorporated: Salè H-1B

5 aplikasyon kondisyon travay pou tit travay Stem Cell Principal Research Associate nan Vertex Pharmaceuticals Incorporated. Salè baz medyàn ofri $99,154; mwatye mitan $93,413–$104,416.

Demann (LCA)5
Salè medyan ofri$99,154
Mwatye salè yo$93,413–$104,416
10yèm–90yèm pousantaj$92,552–$104,416

Pa ane fiskal

Ane fiskalLCASalè medyan
FY20241$93,891
FY20252$104,416
FY20261$91,978

Aplikasyon

Salè bazKoteSoumètDat kòmansmanEstati
$91,978–$130,900
Nivo II
Boston, MAApr 16, 2026Oct 1, 2026Certifye
$104,416–$120,665
Nivo II
Boston, MAApr 28, 2025Oct 1, 2025Certifye
$104,416–$121,392
Nivo II
Boston, MAApr 21, 2025Oct 1, 2025Certifye
$104,416–$127,892
tan pasyèl · Nivo II
Boston, MAMar 20, 2025Sep 19, 2025Certifye
$93,891–$119,814
Nivo II
Boston, MAFeb 8, 2024Jul 27, 2024Certifye

Lòt travay nan Vertex Pharmaceuticals Incorporated

Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).